| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinic and community-based approach to hypertension control for underserved minority population: Design and methods
|
Johnson, Richard A.
|
|
2004
|
|
3 |
p. 76-
1 p.
|
artikel
|
| 2 |
Acute and prophylactic management of migraine
|
Dodick, David W.
|
|
2001
|
|
3 |
p. 36-52
17 p.
|
artikel
|
| 3 |
Antecedents to effective treatment of hypertension in Hispanic populations
|
Soto-Greene, Maria L.
|
|
2004
|
|
3 |
p. 30-38
9 p.
|
artikel
|
| 4 |
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopaus
|
Archer, D.F.
|
|
1999
|
|
3 |
p. 53-
1 p.
|
artikel
|
| 5 |
Assessing psychiatric illness in geriatric patients
|
Tune, Larry
|
|
2001
|
|
3 |
p. 23-33
11 p.
|
artikel
|
| 6 |
A streamlined method for diagnosing common psychiatric disorders in primary care
|
Staab, Jeffrey P.
|
|
2001
|
|
3 |
p. 1-7
7 p.
|
artikel
|
| 7 |
Awareness of hypertension and diabetes in the Hispanic community
|
Aranda Jr, Juan M.
|
|
2004
|
|
3 |
p. 7-15
9 p.
|
artikel
|
| 8 |
A 12-year-old student athlete with exercise-induced bronchospasm: Getting Jenny B. Back on track
|
Mosnaim, Giselle
|
|
2009
|
|
3 |
p. 30-39
10 p.
|
artikel
|
| 9 |
Barriers to health promotion and disease prevention in the Latino population
|
Betancourt, Joseph R.
|
|
2004
|
|
3 |
p. 16-29
14 p.
|
artikel
|
| 10 |
Cardiometabolic risk and risk management
|
|
|
2007
|
|
3 |
p. 3-5
3 p.
|
artikel
|
| 11 |
Cardiovascular disease and modifiable cardiometabolic risk factors
|
Cannon, Christopher P.
|
|
2007
|
|
3 |
p. 11-28
18 p.
|
artikel
|
| 12 |
Chronic insomnia — A challenge for the future
|
Miller, Ellen H.
|
|
2003
|
|
3 |
p. 3-4
2 p.
|
artikel
|
| 13 |
Clinical implications of the insulin resistance syndrome
|
Garvey, W.Timothy
|
|
1998
|
|
3 |
p. 13-28
16 p.
|
artikel
|
| 14 |
Clinical importance of identifying immunoglobulin E-mediated disease in patients with Asthma
|
Casale, Thomas B.
|
|
2009
|
|
3 |
p. 20-29
10 p.
|
artikel
|
| 15 |
Clinical manifestations of migraine
|
Kunkel, Robert S.
|
|
2001
|
|
3 |
p. 18-25
8 p.
|
artikel
|
| 16 |
CME information migraine
|
|
|
2001
|
|
3 |
p. iii-
1 p.
|
artikel
|
| 17 |
CME information obesity
|
|
|
1999
|
|
3 |
p. 54-58
5 p.
|
artikel
|
| 18 |
CME information office psychiatry
|
|
|
2001
|
|
3 |
p. 61-66
6 p.
|
artikel
|
| 19 |
CME information to diabetes
|
|
|
1998
|
|
3 |
p. 72-74
3 p.
|
artikel
|
| 20 |
CME test answers
|
|
|
2004
|
|
3 |
p. 85-87
3 p.
|
artikel
|
| 21 |
CME test answers cardiometabolic risk and risk management
|
|
|
2007
|
|
3 |
p. 89-91
3 p.
|
artikel
|
| 22 |
CME test answer sheet and evaluation form for cardiometabolic risk and risk management
|
|
|
2007
|
|
3 |
p. 87-88
2 p.
|
artikel
|
| 23 |
CME test answer sheet and evaluat ion form for chronic insomnia
|
|
|
2003
|
|
3 |
p. 67-72
6 p.
|
artikel
|
| 24 |
CME test answer sheet and evaluation form for hypertension in hispanics
|
|
|
2004
|
|
3 |
p. 83-84
2 p.
|
artikel
|
| 25 |
CME test answer sheet and evaluation form for migraine
|
|
|
2001
|
|
3 |
p. 69-74
6 p.
|
artikel
|
| 26 |
CME test questions
|
|
|
2004
|
|
3 |
p. 79-81
3 p.
|
artikel
|
| 27 |
CME test questions cardiometabolic risk and risk management
|
|
|
2007
|
|
3 |
p. 83-85
3 p.
|
artikel
|
| 28 |
CME test questions chronic insomnia
|
|
|
2003
|
|
3 |
p. 63-65
3 p.
|
artikel
|
| 29 |
CME test questions migraine
|
|
|
2001
|
|
3 |
p. 66-68
3 p.
|
artikel
|
| 30 |
Cognitive behavior therapy for chronic insomnia
|
Smith, Michael T.
|
|
2003
|
|
3 |
p. 28-40
13 p.
|
artikel
|
| 31 |
Comparative aspects of triptans in treating migraine
|
Adelman, James U.
|
|
2001
|
|
3 |
p. 53-64
12 p.
|
artikel
|
| 32 |
Comprehensive management of cardiometabolic risk factors
|
Early, James
|
|
2007
|
|
3 |
p. 69-80
12 p.
|
artikel
|
| 33 |
Continuing education answer sheet and evaluation form for Diabetes
|
|
|
1998
|
|
3 |
p. 75-76
2 p.
|
artikel
|
| 34 |
Continuing education answer sheet and evaluation form for obesity
|
|
|
1999
|
|
3 |
p. 59-60
2 p.
|
artikel
|
| 35 |
Dyslipidemia and glucose dysregulation in overweight and obese patients
|
LeRoith, Derek
|
|
2007
|
|
3 |
p. 38-52
15 p.
|
artikel
|
| 36 |
Education: Nationally achievable solutions
|
Pepine, Carl J.
|
|
2004
|
|
3 |
p. 65-70
6 p.
|
artikel
|
| 37 |
Etiology and pathogenesis of obesity
|
Bray, George A.
|
|
1999
|
|
3 |
p. 1-15
15 p.
|
artikel
|
| 38 |
Factors influencing unawareness of hypertension among older Mexican Americans
|
Johnson, Richard A.
|
|
2004
|
|
3 |
p. 77-
1 p.
|
artikel
|
| 39 |
From the page to the clinic: Implementing new National Asthma Education and Prevention Program guidelines
|
Rachelefsky, Gary S.
|
|
2009
|
|
3 |
p. 9-19
11 p.
|
artikel
|
| 40 |
Generalized anxiety disorder
|
Gorman, Jack M.
|
|
2001
|
|
3 |
p. 37-43
7 p.
|
artikel
|
| 41 |
Glucose control in type 1 diabetes: From conventional to intensive therapy
|
Zinman, Bernard
|
|
1998
|
|
3 |
p. 29-38
10 p.
|
artikel
|
| 42 |
Hormone replacement therapy and sleep-disordered breathing
|
|
|
2003
|
|
3 |
p. 61-
1 p.
|
artikel
|
| 43 |
Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition
|
Peters, Stephen
|
|
2009
|
|
3 |
p. 50-53
4 p.
|
artikel
|
| 44 |
Hydrofluoroalkane tear-out sheet
|
|
|
2009
|
|
3 |
p. 61-
1 p.
|
artikel
|
| 45 |
Hypertension in ethnic populations: Tailoring treatments
|
Kountz, David S.
|
|
2004
|
|
3 |
p. 39-48
10 p.
|
artikel
|
| 46 |
Inhaled anticholinergics and the long-term treatment of chronic obstructive pulmonary disease: Weighing benefits and risks
|
Hogarth, D. Kyle
|
|
2009
|
|
3 |
p. 45-49
5 p.
|
artikel
|
| 47 |
Insomnia: Epidemiology, characteristics, and consequences
|
Roth, Thomas
|
|
2003
|
|
3 |
p. 5-15
11 p.
|
artikel
|
| 48 |
Insomnia in the geriatric patient
|
Avidan, Alon Y.
|
|
2003
|
|
3 |
p. 51-60
10 p.
|
artikel
|
| 49 |
Insomnia in women
|
Krystal, Andrew D.
|
|
2003
|
|
3 |
p. 41-50
10 p.
|
artikel
|
| 50 |
Intervention study supports homocysteine-lowering treatment to slow progression of atherosclerosis
|
Johnson, Richard A.
|
|
2001
|
|
3 |
p. 58-60
3 p.
|
artikel
|
| 51 |
Intranasal lidocaine for the treatment of migraine headache: A randomised, controlled trial
|
Blanda, M.
|
|
2001
|
|
3 |
p. 65-
1 p.
|
artikel
|
| 52 |
Introdcution
|
Garvey, W.Timothy
|
|
1998
|
|
3 |
p. iv-
1 p.
|
artikel
|
| 53 |
Introduction
|
Rachelefsky, Gary S.
|
|
2009
|
|
3 |
p. 6-8
3 p.
|
artikel
|
| 54 |
Introduction
|
Neubauer, David N.
|
|
2003
|
|
3 |
p. 1-
1 p.
|
artikel
|
| 55 |
Introduction
|
Nesto, Richard W.
|
|
2007
|
|
3 |
p. 9-10
2 p.
|
artikel
|
| 56 |
Introduction
|
Heber, David
|
|
1999
|
|
3 |
p. iv-
1 p.
|
artikel
|
| 57 |
Introduction
|
Quan, Martin
|
|
2001
|
|
3 |
p. iv-v
nvt p.
|
artikel
|
| 58 |
Introduction
|
Mathew, Ninan T.
|
|
2001
|
|
3 |
p. vi-
1 p.
|
artikel
|
| 59 |
Introduction
|
Aranda Jr., Juan M.
|
|
2004
|
|
3 |
p. 5-6
2 p.
|
artikel
|
| 60 |
Issues in achieving compliance with antihypertensive treatment in the Latino population
|
Perez-Stable, Eliseo J.
|
|
2004
|
|
3 |
p. 49-64
16 p.
|
artikel
|
| 61 |
Management of glycemia in type 2 diabetes
|
Buse, John B.
|
|
1998
|
|
3 |
p. 39-57
19 p.
|
artikel
|
| 62 |
Managing the suicidal patient
|
Nicholas, Linda M.
|
|
2001
|
|
3 |
p. 47-54
8 p.
|
artikel
|
| 63 |
New classification and diagnostic criteria for diabetes mellitus
|
Gavin, James R.
|
|
1998
|
|
3 |
p. 1-12
12 p.
|
artikel
|
| 64 |
Obesity and its comorbid conditions
|
Khaodhiar, Lalita
|
|
1999
|
|
3 |
p. 17-31
15 p.
|
artikel
|
| 65 |
Overview
|
Nemeroff, Charles B.
|
|
2001
|
|
3 |
p. vi-
1 p.
|
artikel
|
| 66 |
Overweight and obesity: Key components of cardiometabolic risk
|
Aronne, Louis J.
|
|
2007
|
|
3 |
p. 29-37
9 p.
|
artikel
|
| 67 |
Pathophysiology, epidemiology, and impact of migraine
|
Mathew, Ninan T.
|
|
2001
|
|
3 |
p. 1-17
17 p.
|
artikel
|
| 68 |
Pharmacologic approaches for the treatment of chronic insomnia
|
Neubauer, David N.
|
|
2003
|
|
3 |
p. 16-27
12 p.
|
artikel
|
| 69 |
Pharmacotherapy in the treatment of obesity
|
Heber, David
|
|
1999
|
|
3 |
p. 33-42
10 p.
|
artikel
|
| 70 |
Pitfalls in migraine diagnosis and management
|
Smith, Timothy R.
|
|
2001
|
|
3 |
p. 26-35
10 p.
|
artikel
|
| 71 |
Prevention of diabetes complications
|
Colwell, John A.
|
|
1998
|
|
3 |
p. 58-71
14 p.
|
artikel
|
| 72 |
Publisher's note
|
|
|
2003
|
|
3 |
p. ii-
1 p.
|
artikel
|
| 73 |
Recreational effect against gallbladde disease linked to physical activity
|
Leitzman, M.F.
|
|
1999
|
|
3 |
p. 52-
1 p.
|
artikel
|
| 74 |
Role of stress, arousal, and coping skills in primary insomnia
|
|
|
2003
|
|
3 |
p. 62-
1 p.
|
artikel
|
| 75 |
Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors
|
Johnson, Richard A.
|
|
2007
|
|
3 |
p. 81-
1 p.
|
artikel
|
| 76 |
Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts
|
Quan, Martin
|
|
2009
|
|
3 |
p. 54-60
7 p.
|
artikel
|
| 77 |
The blockade of the endocannabinoid CB1 receptors and its influence on cardiometabolic risk: Lesson from rimonabant in obesity (RIO) trials
|
Johnson, Richard A.
|
|
2007
|
|
3 |
p. 82-
1 p.
|
artikel
|
| 78 |
The central role of lifestyle change in long-term weight management
|
Brownell, Kelly D.
|
|
1999
|
|
3 |
p. 43-51
9 p.
|
artikel
|
| 79 |
The evaluation and treatment of depression in primary care
|
Compton, Michael T.
|
|
2001
|
|
3 |
p. 10-20
11 p.
|
artikel
|
| 80 |
Treatment of hypertension in the hispanic community: Cultural case studies
|
Aranda Jr, Juan M.
|
|
2004
|
|
3 |
p. 71-75
5 p.
|
artikel
|
| 81 |
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors
|
Gerich, John E.
|
|
2007
|
|
3 |
p. 53-68
16 p.
|
artikel
|
| 82 |
Using long-acting β2-agonists safely: What will be the impact of the US Food and Drug Administration's panel recommendations?
|
Smart, Brian A.
|
|
2009
|
|
3 |
p. 40-44
5 p.
|
artikel
|
Tijdschrift beschrijving